ID   KLF3_HUMAN              Reviewed;         345 AA.
AC   P57682; Q6PIR1; Q86TN0; Q9P2X6;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2000, sequence version 1.
DT   07-APR-2021, entry version 183.
DE   RecName: Full=Krueppel-like factor 3;
DE   AltName: Full=Basic krueppel-like factor;
DE   AltName: Full=CACCC-box-binding protein BKLF;
DE   AltName: Full=TEF-2;
GN   Name=KLF3; Synonyms=BKLF;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Matsumoto N., Yoshida T., Terada M.;
RL   Submitted (MAR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=12812068;
RA   Wang M.J., Qu X.H., Wang L.S., Zhai Y., Wu S.L., He F.C.;
RT   "cDNA cloning, subcellular localization and tissue expression of a new
RT   human Kruppel-like transcription factor: human basic Kruppel-like factor
RT   (hBKLF).";
RL   Yi Chuan Xue Bao 30:1-9(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Hippocampus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-250, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-92 AND SER-101, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-92 AND SER-111, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-71; SER-92; SER-101 AND
RP   SER-250, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [9]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-198, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [10]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-68; LYS-196 AND LYS-198, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [11]
RP   INACTIVATION OF 9AATAD MOTIF.
RX   PubMed=31375868; DOI=10.1007/s00018-019-03251-w;
RA   Piskacek M., Havelka M., Jendruchova K., Knight A., Keegan L.P.;
RT   "The evolution of the 9aaTAD domain in Sp2 proteins: inactivation with
RT   valines and intron reservoirs.";
RL   Cell. Mol. Life Sci. 0:0-0(2019).
CC   -!- FUNCTION: Binds to the CACCC box of erythroid cell-expressed genes. May
CC       play a role in hematopoiesis (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Monomer. {ECO:0000250}.
CC   -!- INTERACTION:
CC       P57682; Q86V38: ATN1; NbExp=3; IntAct=EBI-8472267, EBI-11954292;
CC       P57682; P54253: ATXN1; NbExp=3; IntAct=EBI-8472267, EBI-930964;
CC       P57682; Q9Y5Z0: BACE2; NbExp=3; IntAct=EBI-8472267, EBI-11282723;
CC       P57682; P46379-2: BAG6; NbExp=3; IntAct=EBI-8472267, EBI-10988864;
CC       P57682; A0A140G945: CRYAA2; NbExp=3; IntAct=EBI-8472267, EBI-25838900;
CC       P57682; Q13363-2: CTBP1; NbExp=3; IntAct=EBI-8472267, EBI-10171858;
CC       P57682; P56545-3: CTBP2; NbExp=3; IntAct=EBI-8472267, EBI-10171902;
CC       P57682; Q9NX09: DDIT4; NbExp=3; IntAct=EBI-8472267, EBI-715104;
CC       P57682; Q92997: DVL3; NbExp=3; IntAct=EBI-8472267, EBI-739789;
CC       P57682; A2ABF9: EHMT2; NbExp=3; IntAct=EBI-8472267, EBI-10174566;
CC       P57682; Q96KQ7: EHMT2; NbExp=3; IntAct=EBI-8472267, EBI-744366;
CC       P57682; P22607: FGFR3; NbExp=3; IntAct=EBI-8472267, EBI-348399;
CC       P57682; Q13643: FHL3; NbExp=11; IntAct=EBI-8472267, EBI-741101;
CC       P57682; O14908-2: GIPC1; NbExp=3; IntAct=EBI-8472267, EBI-25913156;
CC       P57682; P28799: GRN; NbExp=3; IntAct=EBI-8472267, EBI-747754;
CC       P57682; P01112: HRAS; NbExp=3; IntAct=EBI-8472267, EBI-350145;
CC       P57682; P04792: HSPB1; NbExp=3; IntAct=EBI-8472267, EBI-352682;
CC       P57682; O43464: HTRA2; NbExp=3; IntAct=EBI-8472267, EBI-517086;
CC       P57682; P42858: HTT; NbExp=6; IntAct=EBI-8472267, EBI-466029;
CC       P57682; Q9Y2W7: KCNIP3; NbExp=3; IntAct=EBI-8472267, EBI-751501;
CC       P57682; O60333-2: KIF1B; NbExp=3; IntAct=EBI-8472267, EBI-10975473;
CC       P57682; O14901: KLF11; NbExp=3; IntAct=EBI-8472267, EBI-948266;
CC       P57682; Q92876: KLK6; NbExp=3; IntAct=EBI-8472267, EBI-2432309;
CC       P57682; Q9UPM6: LHX6; NbExp=3; IntAct=EBI-8472267, EBI-10258746;
CC       P57682; Q68G74: LHX8; NbExp=3; IntAct=EBI-8472267, EBI-8474075;
CC       P57682; Q5T3J3: LRIF1; NbExp=3; IntAct=EBI-8472267, EBI-473196;
CC       P57682; Q9BVL2: NUP58; NbExp=3; IntAct=EBI-8472267, EBI-2811583;
CC       P57682; P32243-2: OTX2; NbExp=3; IntAct=EBI-8472267, EBI-9087860;
CC       P57682; O43933: PEX1; NbExp=3; IntAct=EBI-8472267, EBI-988601;
CC       P57682; P60891: PRPS1; NbExp=3; IntAct=EBI-8472267, EBI-749195;
CC       P57682; Q12933: TRAF2; NbExp=6; IntAct=EBI-8472267, EBI-355744;
CC       P57682; O76024: WFS1; NbExp=3; IntAct=EBI-8472267, EBI-720609;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P57682-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P57682-2; Sequence=VSP_014532;
CC   -!- DOMAIN: The 9aaTAD motif is a transactivation domain present in a large
CC       number of yeast and animal transcription factors. In KLF3, the motif is
CC       inactive. {ECO:0000269|PubMed:31375868}.
CC   -!- PTM: Sumoylated with SUMO1. Sumoylation is enhanced by PIAS1,
CC       PIAS2alpha and PIAS2beta, and PIAS4, but not by Pc2. Enhances
CC       transcriptional repression, but has no effect on DNA binding.
CC       Sumoylation on Lys-198 is the major site (By similarity).
CC       {ECO:0000250}.
CC   -!- MISCELLANEOUS: [Isoform 2]: May be due to intron retention.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the krueppel C2H2-type zinc-finger protein
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB024523; BAA92271.1; -; mRNA.
DR   EMBL; AF285837; AAK27329.1; -; mRNA.
DR   EMBL; BC030662; AAH30662.1; -; mRNA.
DR   EMBL; BC051687; AAH51687.1; -; mRNA.
DR   CCDS; CCDS3444.1; -. [P57682-1]
DR   RefSeq; NP_057615.3; NM_016531.5. [P57682-1]
DR   SMR; P57682; -.
DR   BioGRID; 119426; 15.
DR   IntAct; P57682; 35.
DR   MINT; P57682; -.
DR   STRING; 9606.ENSP00000261438; -.
DR   iPTMnet; P57682; -.
DR   PhosphoSitePlus; P57682; -.
DR   BioMuta; KLF3; -.
DR   DMDM; 12644533; -.
DR   EPD; P57682; -.
DR   jPOST; P57682; -.
DR   MassIVE; P57682; -.
DR   MaxQB; P57682; -.
DR   PaxDb; P57682; -.
DR   PeptideAtlas; P57682; -.
DR   PRIDE; P57682; -.
DR   ProteomicsDB; 57007; -. [P57682-1]
DR   ProteomicsDB; 57008; -. [P57682-2]
DR   Antibodypedia; 10444; 183 antibodies.
DR   DNASU; 51274; -.
DR   Ensembl; ENST00000261438; ENSP00000261438; ENSG00000109787. [P57682-1]
DR   Ensembl; ENST00000514033; ENSP00000421252; ENSG00000109787. [P57682-2]
DR   GeneID; 51274; -.
DR   KEGG; hsa:51274; -.
DR   UCSC; uc003gtg.3; human. [P57682-1]
DR   CTD; 51274; -.
DR   DisGeNET; 51274; -.
DR   GeneCards; KLF3; -.
DR   HGNC; HGNC:16516; KLF3.
DR   HPA; ENSG00000109787; Low tissue specificity.
DR   MIM; 609392; gene.
DR   neXtProt; NX_P57682; -.
DR   OpenTargets; ENSG00000109787; -.
DR   PharmGKB; PA30137; -.
DR   VEuPathDB; HostDB:ENSG00000109787.12; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   GeneTree; ENSGT00940000157456; -.
DR   HOGENOM; CLU_002678_33_0_1; -.
DR   InParanoid; P57682; -.
DR   OMA; FMYAPHL; -.
DR   PhylomeDB; P57682; -.
DR   TreeFam; TF350556; -.
DR   PathwayCommons; P57682; -.
DR   SIGNOR; P57682; -.
DR   BioGRID-ORCS; 51274; 24 hits in 1015 CRISPR screens.
DR   ChiTaRS; KLF3; human.
DR   GeneWiki; KLF3; -.
DR   GenomeRNAi; 51274; -.
DR   Pharos; P57682; Tbio.
DR   PRO; PR:P57682; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   RNAct; P57682; protein.
DR   Bgee; ENSG00000109787; Expressed in mouth mucosa and 239 other tissues.
DR   ExpressionAtlas; P57682; baseline and differential.
DR   Genevisible; P57682; HS.
DR   GO; GO:0000785; C:chromatin; ISA:NTNU_SB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; NAS:ProtInc.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISA:NTNU_SB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; IDA:ARUK-UCL.
DR   GO; GO:1901653; P:cellular response to peptide; IEA:Ensembl.
DR   GO; GO:0007275; P:multicellular organism development; TAS:ProtInc.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IEA:Ensembl.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   Pfam; PF00096; zf-C2H2; 3.
DR   SMART; SM00355; ZnF_C2H2; 3.
DR   SUPFAM; SSF57667; SSF57667; 2.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 3.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 3.
PE   1: Evidence at protein level;
KW   Activator; Alternative splicing; DNA-binding; Isopeptide bond;
KW   Metal-binding; Nucleus; Phosphoprotein; Reference proteome; Repeat;
KW   Repressor; Transcription; Transcription regulation; Ubl conjugation; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..345
FT                   /note="Krueppel-like factor 3"
FT                   /id="PRO_0000047165"
FT   ZN_FING         260..284
FT                   /note="C2H2-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         290..314
FT                   /note="C2H2-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         320..342
FT                   /note="C2H2-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   REGION          1..74
FT                   /note="Repressor domain"
FT   MOTIF           60..68
FT                   /note="9aaTAD; inactive"
FT                   /evidence="ECO:0000269|PubMed:31375868"
FT   MOTIF           61..65
FT                   /note="CTBP-binding motif"
FT   COMPBIAS        1..251
FT                   /note="Pro-rich"
FT   MOD_RES         71
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         92
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163"
FT   MOD_RES         101
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         108
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q60980"
FT   MOD_RES         111
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         216
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q60980"
FT   MOD_RES         224
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q60980"
FT   MOD_RES         250
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:23186163"
FT   CROSSLNK        10
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000250"
FT   CROSSLNK        68
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        196
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        198
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:25218447,
FT                   ECO:0007744|PubMed:28112733"
FT   VAR_SEQ         233..345
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_014532"
FT   VARIANT         207
FT                   /note="R -> S (in dbSNP:rs17616226)"
FT                   /id="VAR_052715"
FT   CONFLICT        85
FT                   /note="P -> R (in Ref. 3; AAH51687)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        116
FT                   /note="P -> H (in Ref. 3; AAH51687)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        305
FT                   /note="D -> G (in Ref. 3; AAH30662)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   345 AA;  38829 MW;  A490D642AB8F1FDC CRC64;
     MLMFDPVPVK QEAMDPVSVS YPSNYMESMK PNKYGVIYST PLPEKFFQTP EGLSHGIQME
     PVDLTVNKRS SPPSAGNSPS SLKFPSSHRR ASPGLSMPSS SPPIKKYSPP SPGVQPFGVP
     LSMPPVMAAA LSRHGIRSPG ILPVIQPVVV QPVPFMYTSH LQQPLMVSLS EEMENSSSSM
     QVPVIESYEK PISQKKIKIE PGIEPQRTDY YPEEMSPPLM NSVSPPQALL QENHPSVIVQ
     PGKRPLPVES PDTQRKRRIH RCDYDGCNKV YTKSSHLKAH RRTHTGEKPY KCTWEGCTWK
     FARSDELTRH FRKHTGIKPF QCPDCDRSFS RSDHLALHRK RHMLV
//
